Nanoparticles and Mini-NMR point the way to personalized cancer therapy
Monday, November 21, 2011 - 12:32
in Health & Medicine
(PhysOrg.com) -- With the advent of targeted drug therapy for treating cancer, it has become clear that an important predictor of success of these therapies is whether such a drug is reaching its target in the patient. The bottom-line measure of success is survival, but having some rapid measure of drug targeting would enable oncologists to make early changes in therapy if the amount of drug reaching its intended target was insufficient to kill a tumor.
